Riskpilot← Back to searchSign inGet full accessXenochem AB
ABActiveOrg 5569163800Taggsvampsvägen 12Engineering activities and related technical consultancy · NACE 7112Est. 20121 employees
Revenue 2024
SEK 0
EBITDA margin
—
-14% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -6K
-20% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -8K | -14% |
| Net profit | SEK -6K | -20% |
| Total assets | SEK 186K | -4% |
| Equity | SEK 186K | -4% |
| Employees | 1 | — |
Legal name
Xenochem AB
Org number
5569163800
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
20 december 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva konsulttjänster inom organisk kemi, läkemedelskemi, materialkemi, samt laboratoriesäkerhet. Företaget kommer även att bedriva forskning och utveckling inom organisk kemi och materialkemi, med inriktning mot unika finkemikalier.
Address
Taggsvampsvägen 12
Email
tomasz.janosik@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 | 0 | 32 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | −6 | — | −7 | −8 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −8 | −6 | 0 | −7 | −8 |
| Net financials | — | — | — | 2 | 2 |
| Profit before tax | 47 | −6 | 0 | −5 | −6 |
| Tax | −10 | −0 | −0 | −0 | −0 |
| Net profit | 37 | −6 | 0 | −5 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 204 | 198 | 198 | 193 | 186 |
| Equity | 204 | 198 | 198 | 193 | 186 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 |
| Total debt | — | — | — | — | — |
EBITDA margin
-800000.0%
This company
15.8%
Market median
-5063391% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20202024
Net profit margin
-600000.0%
This company
8.1%
Market median
-7407507% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Xenochem AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tomasz Janosik | Chairman | 0 companies |
| Niklas Håkan Wahlström | Board of Directors | 0 companies |
| Johnny Gunnar Stefan Slätt | Board of Directors | 0 companies |